Hypothesis generative head-to-head study comparing efficacy of afatinib and osimertinib based on immunological biomarkers in Japanese NSCLC patients with EGFR mutations (Heat on Beat study)-MedSci.cn

Hypothesis generative head-to-head study comparing efficacy of afatinib and osimertinib based on immunological biomarkers in Japanese NSCLC patients with EGFR mutations (Heat on Beat study)

Morikawa, K; Tanaka, H; Itani, H; Takata, S; Watanabe, S; Kishi, K; Soejima, K; Kaira, K; Kagamu, H; Yoshimura, K; Matsutani, N; Seki, N

Seki, N (corresponding author), Teikyo Univ, Sch Med, Div Med Oncol, Dept Internal Med,Itabashi Ku, 2-11-1 Kaga, Tokyo 1738606, Japan.

Abstract

Background: In the FLAURA trial, superiority of osimertinib over the standard of care (SOC) was not demonstrated in Asian patients; SOC seemed favorab......

Full Text Link

Links

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

Hypothesis generative head-to-head study comparing efficacy of afatinib and osimertinib based on immunological biomarkers in Japanese NSCLC patients with EGFR mutations (Heat on Beat study)

科室

工具

服务